Danaher North America — Sales increased by 6.8% to $2.76B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.6%, from $2.77B to $2.76B. Over 4 years (FY 2021 to FY 2025), North America — Sales shows a downward trend with a -3.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests strong regional demand, successful product adoption, or effective pricing strategies, while a decrease may indicate market saturation, increased competition, or regional economic headwinds.
This metric represents the total revenue generated from products and services sold within the North American geographic...
Peers in the life sciences and diagnostics sectors typically report regional revenue to demonstrate geographic diversification and market share stability.
dhr_segment_north_america_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.82B | $2.89B | $3.40B | $3.35B | $3.38B | $3.48B | $3.75B | $3.02B | $2.93B | $2.97B | $1.04B | $2.63B | $2.43B | $2.46B | $2.77B | $2.58B | $2.44B | $2.58B | $2.76B |
| QoQ Change | — | +2.5% | +17.8% | -1.4% | +0.8% | +2.9% | +7.8% | -19.5% | -3.1% | +1.6% | -65.1% | +153.6% | -7.5% | +0.9% | +12.9% | -6.9% | -5.6% | +5.8% | +6.8% |
| YoY Change | — | — | — | — | +20.1% | +20.6% | +10.4% | -9.9% | -13.5% | -14.5% | -72.3% | -12.9% | -16.8% | -17.4% | +167.1% | -1.9% | +0.2% | +5.0% | -0.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.